Editas Medicine Inc (NASDAQ:EDIT)

BATS BZX Real-Time Price
As of 11:41am ET
 -6.50 / -15.86%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Editas Medicine Inc have a median target of 42.50, with a high estimate of 81.00 and a low estimate of 14.00. The median estimate represents a +23.22% increase from the last price of 34.49.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Editas Medicine Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 23.85%
Growthannually -66.43%


Growthquarterly -55.00%
Growthannually -77.01%
Key to the earnings and sales forecast charts.